Explore the Advancing Community Oncology Report to get exclusive insights from 200+ community oncologists and administrators alongside perspectives from leading oncologists and McKesson leaders. Download report: bit.ly/4pCAhNu
This Veterans Day, we’re proud to recognize the veterans across McKesson and beyond whose service has made a lasting difference.
Thank you to all who have served.
#VeteransDay
Behind every new therapy is a patient waiting for better options. With the close of our acquisition of Precision Medicine Group, we’re adding complementary capabilities across clinical development, commercialization and patient access to help new therapy options reach patients.
As therapies become more targeted, time-sensitive and complex, pharmaceutical supply chains must evolve. At LogiPharma USA, McKesson leaders discussed how earlier demand signals, visibility and collaboration can support reliable patient access. Read more: bit.ly/3WjvAyz
Cell and gene therapies are advancing, but patient access is only part of the story. The 2026 Cell and Gene Therapy Report from InspiroGene by McKesson examines use in oncology, emerging opportunities and remaining needs. Explore the findings: bit.ly/4zhhD2D
00:00
Wait! Don't Go Yet 🚀
Get our FREE eBook "10 Programming Tips That Changed Everything" when you subscribe to our newsletter!